We have used gene targeting in embryonic stem cells to introduce an HP
RT mini-gene into the coding sequence of the murine cystic fibrosis ge
ne (cftr). This insertion introduces a termination codon in frame with
the cftr coding sequence to terminate prematurely the CFTR protein wi
thin the first nucleotide binding domain. Animals homozygous for the c
ftr disruption fail to thrive and display a range of symptoms includin
g meconium ileus, distal intestinal obstructions, gastrointestinal muc
us accumulation and blockage of pancreatic ducts. The animals also sho
w lacrimal gland pathology. Tracheal and caecal transepithelial curren
t measurements demonstrate the lack of a cAMP activatable Cl- channel.
These animals will prove useful for the evaluation of new therapeutic
drugs and gene therapy strategies.